Cargando…
Frozen thawed embryo transfer cycles; A comparison of pregnancy outcomes with and without prior pituitary suppression by GnRH agonists: An RCT
BACKGROUND: To perform an in-vitro fertilization cycle, pretreatment with gonadotropin-releasing hormone (GnRH) agonist is widely used as a part of controlled ovarian hyper-stimulation protocols to prevent endogenous luteinizing hormone surge and spontaneous ovulation. GnRH agonist pretreatment is r...
Autores principales: | Samsami, Alamtaj, Chitsazi, Zohre, Namazi, Golnaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312713/ https://www.ncbi.nlm.nih.gov/pubmed/30643866 |
Ejemplares similares
-
Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT
por: Davar, Robab, et al.
Publicado: (2015) -
Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT
por: Zareii, Afsoon, et al.
Publicado: (2021) -
Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol
por: Eftekhar, Maryam, et al.
Publicado: (2012) -
Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?
por: Xu, Bin, et al.
Publicado: (2023) -
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
por: Depalo, Raffaella, et al.
Publicado: (2012)